Mubadala Investment Company has expanded its presence in the UAE’s healthcare sector by acquiring an 80 per cent stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH). GHH, the healthcare division of Yas Holding, will retain a 20 per cent stake in both companies.
This move strengthens Mubadala’s position in two key areas of healthcare: medical supply chain logistics and pharmaceutical distribution. GMSC, founded in 2015, provides end-to-end supply chain services for medical products, supporting over 200 medical facilities across the UAE. IDS, established in 1987, is a leading distributor of pharmaceutical and consumer healthcare products, covering a broad range of therapeutic areas and serving hospitals, pharmacies, and supermarkets across the UAE.
Ismail Ali Abdulla, Executive Director at Mubadala, highlighted the acquisition’s significance, noting its role in meeting the increasing demand for specialised drug logistics and reinforcing the UAE’s global healthcare position. The acquisition aligns with Mubadala’s broader strategy to consolidate investments in life sciences and enhance the country’s healthcare sector, contributing to economic diversification and improving healthcare outcomes.
Low Ping, Group CEO of Yas Holding, underlined the deal’s strategic importance, following Mubadala’s recent acquisition of a 100 per cent stake in four pharmaceutical assets from GHH. GlobalOne Healthcare Holding, as part of Yas Holding, continues to focus on innovative healthcare solutions to enhance delivery and outcomes in the UAE.
